Fund shareholders of PROQR THERAPEUTICS NV
ISIN NL0010872495 · Netherlands · LEI 549300NGS2FJGGDBGS06
- Fund shareholders
- 6
- Of which ETFs
- 1 5 other funds
- Value held
- 1.4M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 620,000 | 1.2M $ | 0.15 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 84,909 | 134.2K $ | 0.00 % | as of May 31, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 48,328 | 76.4K $ | 0.40 % | as of May 31, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Multi-Asset Fund | 22,141 | 41.2K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 7,600 | 14.1K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 405 | 696.6 $ | 0.00 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.40 % | as of May 31, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 0.15 % | as of Jun 30, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Multi-Asset Fund | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 0.00 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 0.00 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 6 | 0 | 783,383 | +5.1 % |
| 2026Q2 | 6 | -1 | 745,239 | -40.6 % |
| 2026Q1 | 7 | +1 | 1,254,950 | -0.2 % |
| 2025Q4 | 6 | 0 | 1,257,543 | +0.2 % |
| 2025Q3 | 6 | -4 | 1,255,513 | -6.2 % |
| 2025Q2 | 10 | +2 | 1,337,979 | +7.2 % |
| 2025Q1 | 8 | 0 | 1,248,380 | -18.6 % |
| 2024Q4 | 8 | +3 | 1,532,976 | +126.8 % |
| 2024Q3 | 5 | 0 | 675,963 | -0.2 % |
| 2024Q2 | 5 | -1 | 677,228 | -3.0 % |
| 2024Q1 | 6 | 0 | 698,254 | +1.7 % |
| 2023Q4 | 6 | 686,742 |
Cite this page
Titelia. "Fund shareholders of PROQR THERAPEUTICS NV". https://titelia.com/en/stocks/proqr-therapeutics-nv-NL0010872495